RespireRx Pharmaceuticals Inc.
Pharmaceutical company · Glen Rock, New Jersey, United States
RespireRx Pharmaceuticals Inc. is a pharmaceutical company headquartered in Glen Rock, New Jersey, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.5 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $193,250 sold in a notice filed in 2020.
RespireRx Pharmaceuticals at a glance
What does RespireRx Pharmaceuticals do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $1.5 million in total (2025). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
14 Form D notices; the most recent reported $193,250 sold (2020).
Frequently asked questions about RespireRx Pharmaceuticals
Where is RespireRx Pharmaceuticals headquartered?
RespireRx Pharmaceuticals Inc. is headquartered in Glen Rock, New Jersey, United States.
What does RespireRx Pharmaceuticals do?
RespireRx Pharmaceuticals Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences